Department of Cardiology, Cardiovascular Research Institute Maastricht (CARIM), Maastricht University Medical Center (MUMC+), Maastricht, The Netherlands.
Department of Cardiology, Radboud University Medical Center (Radboudumc), Nijmegen, The Netherlands.
Europace. 2021 Apr 10;23(23 Suppl 2):ii40-ii45. doi: 10.1093/europace/euaa368.
Atrial fibrillation (AF) and heart failure (HF) are both highly prevalent diseases and are accompanied by a significant disease burden and increased mortality. Although the conditions may exist independently, they often go hand in hand as each is able to provoke, sustain, and aggravate the other. In addition, the diseases share a risk profile with several coinciding cardiovascular risk factors, promoting the odds of developing both AF and HF separately from each other. When the diseases coexist, this provides additional challenges but also opportunities for the optimal treatment. The recommended management of the comorbidities has been much debated in the past decades. In this review, we describe the pathophysiological coherence of AF and HF, illustrate the current knowledge on the management of them as comorbidities of each other and look forward to future developments in this field.
心房颤动(AF)和心力衰竭(HF)都是高发疾病,伴随着巨大的疾病负担和死亡率的增加。尽管这两种疾病可能独立存在,但它们往往相伴而生,因为每一种疾病都能引发、维持和加重另一种疾病。此外,这些疾病与一些心血管危险因素并存,增加了分别患上 AF 和 HF 的几率。当这些疾病同时存在时,这不仅带来了更多的挑战,也为最佳治疗提供了更多的机会。过去几十年,人们对这两种合并症的治疗管理进行了大量的讨论。在这篇综述中,我们描述了 AF 和 HF 的病理生理学相关性,阐述了目前关于这两种疾病作为合并症相互管理的知识,并展望了这一领域的未来发展。